Implementation of a Reliable Next-Generation Sequencing Strategy for Molecular Diagnosis of Dystrophinopathies

Diagnosis of dystrophinopathies needs to combine several techniques for detecting copy number variations (CNVs; two-thirds of mutations) and single nucleotide variations (SNVs). We participated in the design of an amplicon-based PCR kit (Multiplicom) for sequencing with a GS-Junior instrument (Roche) and later with a MiSeq instrument (Illumina). We compared two different software programs, MiSeq Reporter (Illumina) and SeqNext (JSI Medical Systems) for data analyses. Testing of six patient DNA samples carrying 72 SNVs in the DMD gene showed an experimental sensitivity of 91.7% with MiSeq Reporter, 98.6% with SeqNext, and>99.9% with both, demonstrating the need to use two different software programs.

Source: Journal of Molecular Diagnostics - July 13, 2016 Category: Pathology Authors: Melissa Alame, Delphine Lacourt, Reda Zenagui, D éborah Mechin, Fabienne Danton, Michel Koenig, Mireille Claustres, Mireille Cossée Tags: Regular Article Source Type: research